Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed
To register the follow-up data of patients who, because of a peritoneal surface malignancy,
will undergo cytoreductive surgery and HIPEC. In this surgical intervention, the abdominal
cavity is macroscopically cleared of tumor, by removing all visible tumor nodules, and is
subsequently rinsed with hyperthermic (heated) chemotherapy, aiming to destroy all residual
invisible tumor cells that might have stayed behind after the debulking.
The eventual aim of this procedure is to improve the prognosis/survival of patients with
malignancies localized on the peritoneal surface.
Observational Model: Case-Only, Time Perspective: Prospective
To improve the prognosis/survival of patients with malignancies localized on the peritoneal surface.
Follow-up over a time period of at least 5 years
André JL D'Hoore, PhD
University Clinics Gasthuisberg Department of Abdominal Surgery
Belgium: Ethics Committee